In a March 2020 webinar at the beginning of the COVID-19 pandemic, RNA vaccine pioneer Dr. Andy Geall explained the technologies necessary for building a successful RNA vaccine development program and tells his story of successfully demonstrating rapid pandemic response based on self-amplifying RNA vaccines.
Learn More About Developing RNA Vaccines
NanoMedU courses
combine classroom education with hands-on learning in the lab to teach specialized techniques and technologies to help accelerate non-viral genomic medicine development.
Early Pre-clinical Level 1: RNA Vaccines covers fundamentals of designing and developing RNA
Lipid Nanoparticles (RNA LNPs), including the four pillars of a successful RNA vaccine program, to help biotech professionals kickstart their RNA vaccine development.